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Background: Viral infections such as influenza have been shown to predispose hosts to increased colonization of
the respiratory tract by pathogenic bacteria and secondary bacterial pneumonia. To examine how viral infections
and host antiviral immune responses alter the upper respiratory microbiota, we analyzed nasal bacterial composition
by 16S ribosomal RNA (rRNA) gene sequencing in healthy adults at baseline and at 1 to 2 weeks and 4 to 6 weeks
following instillation of live attenuated influenza vaccine or intranasal sterile saline. A subset of these samples was
submitted for microarray host gene expression profiling.
Results: We found that live attenuated influenza vaccination led to significant changes in microbial community
structure, diversity, and core taxonomic membership as well as increases in the relative abundances of Staphylococcus
and Bacteroides genera (both p < 0.05). Hypergeometric testing for the enrichment of gene ontology terms in the
vaccinated group reflected a robust up-regulation of type I and type II interferon-stimulated genes in the vaccinated
group relative to controls. Translational murine studies showed that poly I:C administration did in fact permit greater
nasal Staphylococcus aureus persistence, a response absent in interferon alpha/beta receptor deficient mice.
Conclusions: Collectively, our findings demonstrate that although the human nasal bacterial community is
heterogeneous and typically individually robust, activation of a type I interferon (IFN)-mediated antiviral
response may foster the disproportionate emergence of potentially pathogenic species such as S. aureus.
Trial registration: This study was registered with Clinicaltrials.gov on 11/3/15, NCT02597647.
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Secondary bacterial pneumonia has been implicated as
the main cause of death during influenza pandemics,
including the 1918 “Spanish” and 2009 novel H1N1 in-
fluenza A virus pandemics [1–3]. The worldwide death
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medical systems, bacterial co-infection remained a compo-
nent of as many as 30 % of cases of H1N1 infection [6], evi-
dent in 29 % of post-autopsy lungs in one series [3]. The
organisms identified by culture-dependent methods were
predominantly Staphylococcus and Streptococcus species,
with relatively higher proportions of Streptococcus pneumo-
niae and Staphylococcus aureus specifically [3, 6, 7].
While the lower respiratory tract had classically been
considered sterile, there is growing evidence that it
harbors its own microbiota [8, 9] and that this niche is
informed to some extent by the contents of the nasopha-
ryngeal and oral compartments [10–14]. Colonization ofle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Table 1 Characteristics of the volunteers
Healthy volunteer Healthy volunteer
Saline controls (n = 7) LAIV (n = 10)
Age, mean (range) 21.3 (18–25) years 23.8 (18–32) years
Gender (% female) 23.5 % 29.4 %
Student (%) 100 % 70 %
Nose-picking
Never 14.3 % 20 %
Weekly 71.4 % 50 %
Daily 14.3 % 30 %
Values noted are means with ranges expressed for the age. In addition to that
noted above, all volunteers had no recent smoking history, did not swim,
predominantly showered rather than bathed, and used no probiotics or
antibiotics within 90 days of enrollment
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be an essential precursor to the lower respiratory tract and
other invasive bacterial infections or co-infection [15–19].
In murine systems, colonization by potentially pathogenic
bacteria such as S. pneumoniae also appears to be en-
hanced in the presence of type I interferon (IFN) [20].
Murine models have demonstrated that both type I and
type II IFN-mediated host responses to influenza infection
act to critically suppress the antibacterial response against
pulmonary infection by both S. pneumoniae and S. aureus
[21–27]. Whether alterations in nasal colonization pat-
terns occur during viral infections in human beings was
unknown. Presumably, such a virally mediated change
may permit the emergence or overgrowth of potentially
pathogenic bacteria as a precursor to secondary bacterial
infection. Further understanding of such a process would
be essential towards the development of new interventions
or preventative modalities that might depend on temper-
ing the adverse changes in the nasal microbiota and/or
host response.
We therefore addressed two questions in this study:
We examined (1) how a new viral stimulus affected the
upper respiratory tract microbiota and (2) its impact on
host immune response to observe if any associations
existed between the host immune response to the intra-
nasal live attenuated vaccine (LAIV) and changes in bac-
terial composition. This nasal spray vaccine contains
live, attenuated influenza viruses that are cold-adapted
and temperature-sensitive, thereby preferentially repli-
cating in the nares but not the lower respiratory tract.
Live attenuated influenza vaccine is designed to induce
an immune response that mimics the one generated by
live influenza [28].
To determine how the nasal microbiota changes dur-
ing the acute, early recovery, and late recovery periods
after viral perturbation, we analyzed serial nasal samples
from healthy volunteers who were experimentally inoc-
ulated with LAIV. In order to examine potential host
interactions in the setting of viral perturbation, we pro-
filed host gene expression by microarray analysis after
LAIV administration with a focus on type I and type II
interferon-stimulated genes. As Staphylococcus emerged
as one of the genera whose relative abundance increased
following LAIV administration, we then validated our ob-
servations with a murine model looking at the association
between interferon induction and nasal persistence of S.
aureus.
Results
Volunteer characteristics and samples analyzed
We recruited healthy adult subjects who were randomized
to receive either nasal LAIV or sterile nasal saline spray.
Their nares were sampled at baseline (visit 1), 1–2 weeks
(visit 2), and 4–6 weeks (visit 3) after intervention. A totalof 17 volunteers completed all three visits of the study,
with 10 volunteers administered LAIV and 7 receiving sa-
line nasal spray (control group). The baseline characteris-
tics of these volunteers are presented in Table 1. Both
groups were comparable in age and gender distributions.
Most subjects reported either weekly or daily nose-
picking, which has been associated with S. aureus nasal
carriage [29].
Changes in nasal diversity following LAIV versus saline
administration
To determine how the diversity of the nasal microbiota
changes following intranasal influenza vaccine in com-
parison to the microbiota of volunteers having received
only the nasal saline spray (control), we obtained serial
nasal samples and sequenced hypervariable regions of
the 16S ribosomal RNA (rRNA) gene amplified from the
isolated bacterial DNA. We obtained median values of
5489 (σ = 1291) and 7495 (σ = 1524) high-quality se-
quence reads per sample, for the V3–V5 and V1–V3
regions, respectively [30, 31]. In general, the V3–V5
primers resulted in the identification of more taxonomic
units when compared to the V1–V3 primers (data not
shown), particularly in the groups receiving nasal influ-
enza vaccine. As a result, we focused all LAIV and con-
trol group analyses on sequencing from V3–V5 regions.
At the genus level, taxonomic diversity was measured
with the Shannon and Tail (τ) statistic [32] diversity indices,
the latter being a more sensitive measure of diversity in the
presence of low abundance taxa. Both the Tail statistic and
the Shannon index demonstrated statistically significant
within subject differences over time by two-way, repeated
measures ANOVA (p = 0.047 and p = 0.032, respectively).
Subsequent Wilcoxon signed-rank testing without correc-
tion for multiple testing revealed significant changes in both
measures between the first and second visits and the sec-
ond and third visits in the LAIV group, but no significant
changes were seen in the control group (Fig. 1).
A B
Fig. 1 Measures of diversity in LAIV and control groups, by visit as ascertained by hypervariable regions V3–V5 sequencing. a demonstrates
calculated tail statistics at all time points for either group (LAIV visit 1 to 2 p = 0.020; LAIV visit 2 to 3 p = 0.017). b demonstrates Shannon indices
for all time points (LAIV visit 1 to 2 p = 0.014; LAIV visit 2 to 3 p = 0.049). (*p < 0.05 by Wilcoxon signed-rank testing)
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saline administration
We next sought to determine whether the community
structures of either group did in fact change over time.
In order to quantitatively represent these differences
while accounting for inter-subject variability, we con-
ducted a permutational multivariate analysis of variance
(PERMANOVA) based on Bray-Curtis dissimilarities be-
tween all samples, stratified by subject. The interaction
between the intervention (LAIV versus control) and time
proved significant (p = 0.032), with a medium effect (R2
= 0.17). To study these differences within the individual
groups, PERMANOVA was repeated for each group overA
Fig. 2 (See legend on next page.)the first two time points, when treatment-induced
effects were predicted to be the greatest. The control
group showed no significant changes in community
structure over time (p = 0.28, R2 = 0.047), while the LAIV
group changed significantly (p = 0.006, R2 = 0.10). These
relationships were visually demonstrated by multidimen-
sional scaling (MDS) plots based on the same dissimilar-
ity measures (Fig. 2).
Within a cohort, microbiota variability may be attrib-
uted in a small part to sampling and sequencing variabil-
ity, but more largely, to differences between individuals.
Environmental conditions of a body habitat have been
seen to limit microbiota variability; thus, a comparisonB
(See figure on previous page.)
Fig. 2 Multidimensional scaling plots demonstrating genus-level dissimilarities by Bray-Curtis indices between the first two visits in the control
(a) and LAIV (b) groups. Data points from the first visits are in blue, while the second visits are in red. Circles represent respective
centroid locations. V1 = visit 1, V2 = visit 2
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vide information about changing conditions of a body
habitat due to treatment. This variability can be mea-
sured by first quantifying the microbiome variance
within each cohort and then testing for heteroscedasti-
city (i.e., non-constant variance) across cohorts. An
analysis comparing the level of within group variability
over time was performed based on the Bray-Curtis
dissimilarities within each group (LAIV or control by
visit), as measured by the average distance of samples
from the centroid of each group. This analysis revealed a
reduction in variability among the LAIV treated subjects
at visits 2 and 3, compared to visit 1 (p < 0.0001 for
both) (Additional file 1: Figure S1). The control group’s
variance remained constant, i.e., was not heteroscedastic.
This decrease in microbiome variability within the LAIV
cohort further supports the notion that the LAIV treat-
ment had an effect on the nasal habitat of the LAIV co-
hort. This may imply that conditions of the nasal habitat
were changed by LAIV inoculation such that less vari-
ability in the microbiota was supportable.Table 2 Mean relative abundance of detected phyla and genera by
Controls


















Streptophyta 1.21 1.79Genus and phylum level differences following LAIV versus
saline control
We next examined how the nasal microbiota changed at
the genus and phylum levels following LAIV versus saline
administration. Analysis of the sequences for the V3–V5
regions revealed the presence of four prominent phyla
(Actinobacteria, Firmicutes, Proteobacteria, and Bacteroi-
detes), which accounted for more than 90 % of all discov-
ered taxa (Table 2). Over 75 % of the sequences mapped
to 12 genera, 7 of which were ubiquitous in more than
95 % of the samples (Corynebacterium, Propionibacter-
ium, Actinomycetales, Staphylococcus, Streptococcus, “Ba-
cilli class,” and Bacillales). At baseline, the relative
abundances of most of the major genera in either the
LAIV or control groups were comparable in terms of the
order, although the mean values differed, demonstrating
inter-subject variability. Corynebacterium had the highest
mean abundance, followed by Staphylococcus. The relative
abundance of the major genera within individuals was
similar between V1–V3 and V3–V5 regions. The only
exception was Moraxella, which was unexpectedlygroup and visit
LAIV
Visit 3 (%) Visit 1 (%) Visit 2 (%) Visit 3 (%)
35.42 45.97 23.52 38.96
25.16 34.44 15.40 30.86
8.00 6.66 6.21 5.35
1.60 3.09 1.42 2.16
41.56 40.71 51.34 44.99
25.28 19.04 26.37 24.53
0.49 8.37 4.68 4.26
4.10 3.60 4.80 4.32
2.74 1.85 2.56 2.55
13.34 5.28 6.92 5.01
10.51 0.68 0.02 0.12
0.87 0.03 1.26 0.07
0.18 3.29 1.69 0.47
0.04 2.60 7.87 4.95
0.01 0.00 6.26 4.13
1.41 1.04 3.66 3.65
1.40 1.03 3.58 0.88
Table 2 Mean relative abundance of detected phyla and genera by group and visit (Continued)
Fusobacteria 0.042 0.023 3.88 0.61 1.78 1.17
Phylum cumulative 96.35 97.51 95.65 96.21 95.09 98.73
Genera cumulative 79.76 85.13 80.34 82.08 74.25 79.70
The above shown are average relative abundances of the 6 most abundant phyla and 12 most abundant genera by group based on V3–V5 sequencing. Phyla are
listed on the left while their corresponding genera are indented beneath. All OTUs had a ubiquity of over 90 % except Moraxella, Pseudomonas,
Enterobacteriaceae, and Bacteroides. Bacteroides was notably almost exclusively present in the LAIV groups on visits 2 and 3. Cumulative genera and phyla
representation is noted at the bottom
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uals in the control group by V3–V5 sequencing, but not
by V1–V3.
Since we expected our interventions would have the
highest effect at the first follow-up visit, we compared
first visit and second visit samples on a taxon-by-
taxon level utilizing a ubiquity-ubiquity (U-U) plot.
The U-U plot visualizes how the ubiquity, i.e., the
prevalence, of a taxon differs between the microbiotas
of two groups at the same relative abundance thresh-
old [33]. A curve is drawn for each taxon that repre-
sents any changes in ubiquity between the cohortFig. 3 Ubiquity-ubiquity plot depicting the change in ubiquities for selecte
relative abundances between visits 1 and 2 in the LAIV group as ascertaine
relative abundance greater than 0.5 % with a change in ubiquity greater th
the diagonal were more ubiquitous during visit 1, while those to the left w
are the closest, most confident taxonomic assignment that could be givendepicted on the y-axis and the cohort on the x-axis,
thereby identifying which taxa are most shifted be-
tween cohorts. Curves that fall closest to the thick
gray diagonal line represent taxa for which the ubiq-
uities are nearly identical for all abundances between
the two cohorts. The U-U plot comparing the first
and second visits of the LAIV and the control cohort
with detectable levels (set to a threshold of 0.5 %
relative abundance) of individual genera can be found
in Fig. 3 and Additional file 2: Figure S2, respectively.
We found that a higher percentage of subjects had
Bacteroides and Staphylococcus present at visit 2d taxa using operational taxonomic units (OTUs) across the range of
d by hypervariable regions V3–V5 sequencing. Only OTUs with a
an 20 % were included in this plot. OTUs that aligned to the right of
ere more ubiquitous at visit 2. The taxonomic classifications labeled
to the OTU in question
A B
Fig. 4 Absolute changes in relative abundance in the top five changed taxa in the control (a) and LAIV (b) groups as ascertained by hypervariable
regions V3–V5 sequencing (in the LAIV group, Staphylococcus p = 0.048, Bacteroides p = 0.013). (*p < 0.05 by Wilcoxon signed-rank testing)
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oides was undetectable in all subjects in the LAIV
and control groups at baseline but reached a relative
abundance of 10 % or more in 4/10 subjects in the
LAIV group at visit 2. In addition, we identified the
core taxa in each group by examining individual
ubiquity-abundance (Ub-Ab) plots of each group of
samples (Additional file 3: Figure S3). At a ubiquity
threshold of 80 % and relative abundance threshold of
0.5 %, Corynebacterium, Staphylococcus, and Propionibac-
terium emerge as the core taxa at both time points in the
control group and at the first visit in the LAIV group. The
core taxa expanded by the second visit in the LAIV group
to include Staphylococcus, Streptococcus, Corynebacter-
ium, Propionibacterium, and Bacillales.
We next examined changes in the relative abun-
dances of individual bacterial taxa, focusing on the
most abundant bacterial taxa after LAIV administra-
tion (Fig. 4). We observe from the V3–V5 data abso-
lute changes in the relative abundances of the genera
that varied the most over time. While the control
group displayed little change from baseline, the LAIV
group had a notable decrease in the relative abun-
dance of Corynebacterium and statistically significant
increases in Staphylococcus and Bacteroides (p < 0.05
for both by Wilcoxon rank sum testing). Alternatively,
such findings may also be explained by a reduction in
other taxa and therefore may not represent an explicit
increase in burden but could imply a greater relative
representation.
Given that Staphylococcus species could cause inva-
sive infections, we examined the temporal changes of
this genus. At baseline, 4 out of the 7 subjects in thecontrol group and 5 out of 10 subjects in the LAIV
group had Staphylococcus detectable at a relative
abundance above 10 %. Over time, the relative abun-
dance of Staphylococcus in these individuals remained
high (>10 %). Among the individuals who began with
a relatively lower baseline level of Staphylococcus (i.e.,
below 10 %), the 3 subjects in control group continu-
ally demonstrated low levels of Staphylococcus
throughout the study. In contrast, all of the 5 subjects
in the LAIV group who began with a relative abun-
dance of Staphylococcus below 10 % demonstrated a
relative increase in abundance after LAIV administra-
tion, which subsequently remained elevated during
the study (range 7–33 % at visit 2, 13–46 % at visit 3;
Additional file 4: Figure S4). Hence, it appears that
there are intrinsic factors that govern Staphylococcus
persistence in the nares at a relatively high level in
certain individuals over time. However, in a subset of
individuals who do not have relatively high baseline
levels of Staphylococcus, LAIV administration may be
associated with increased colonization and persistence
of Staphylococcus species, although the individual species
could not be distinguished with sufficient confidence
through the 16S regions sequenced in this study.
Correlations between different genera
To identify the potential for taxonomic relationships
among the detected bacteria, a correlation analysis
was performed across the most abundant genera.
Given the compositional aspect of the relative abun-
dance data, the data was necessarily transformed by
using the additive log ratio (ALR) transformation in
order to eliminate spurious correlations. This was
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genera by the sum of the remaining relative abun-
dances of the non-top 15 genera, followed by the nat-
ural logarithm transform [34]. A correlation matrix
was constructed for the most abundant genera, (Add-
itional file 5: Table S1) based on the control and
LAIV cohort. This revealed statistically significant (α
= 0.05) positive correlations (measures using Pearson’s
correlation coefficient, ρ) between Propionibacterium
and Staphylococcus (ρ = 0.52) and Dolosigranulum and
Corynebacterium (ρ = 0.69), and a negative correlation
between Dolosigranulum and both Streptophyta (ρ = −0.52)
and Anaerococcus (ρ = −0.49). However, when corrected for
multiple testing, the correlations were no longer statistically
significant, most likely due to the small sample size used in
the analysis.
In addition, we obtained serial nasal samples from out-
patients presenting to the clinic or our emergency de-
partment with acute flu-like illness (FL). These samples
were not included in the larger study because only 6 out
of the 19 samples could be determined by the respiratory
virus panel to be influenza A positive. However, they
represent an important analog of viral stimulus to the
upper respiratory tract microbiota human response when
compared to vaccination using the LAIV. A pair-wise cor-
relation comparison between the three cohorts (control,
LAIV, and FL) was not performed due to the small cohort
sizes. However, to determine if the previously identified re-
lationships detected in the control and LAIV cohort would
still hold in this larger dataset, the correlation analysis was
repeated, this time utilizing all three cohorts (control,
LAIV, and FL). Analysis of the samples including the
FL cohort was performed on V1–V3 data, for which we
had the most complete sequencing. When all three co-
horts were combined and the correlation analysis was
repeated, the correlations between Propionibacterium
and Staphylococcus were strengthened (ρ = 0.55). The
positive relationship between Dolosigranulum and Cor-
ynebacterium weakened (ρ = 0.56 from ρ = 0.69), and
the negative relationship between Dolosigranulum and
Streptophyta (ρ = −0.21 from ρ = −0.52) and Anaerococcus
(ρ = −0.02 from (ρ = −0.49) also faded. The combined ana-
lysis (Additional file 6: Table S2), also identified additional
taxonomic relationships, albeit less strong (0.19 < |ρ|), that
were statistically significant, especially if a correction for
multiple testing were to be applied. In summary, the FL
cohort showed small differences from both the LAIV and
control group, but due to the small sample sizes of each
cohort and the relatively large interpersonal variation of
each individual’s microbiota, the effects did not appear to
be statistically significant. However, collectively, these ana-
lyses determined consistently positive correlations be-
tween Staphylococcus and Propionibacterium, suggesting
that the most abundant genera move in unison [34].LAIV induces changes in nasal epithelial gene expression
profiles, promoting the expression of interferon types I
and II stimulated genes
To determine whether bacterial colonization might be
influenced by host immune responses to LAIV, we con-
currently sampled the nasal epithelium at each visit to
examine host gene expression by microarray analysis.
A total of 18 samples were obtained from 6 subjects in
the LAIV group and 3 subjects in the control group
concurrently with microbiota sampling (i.e., baseline
and 1–2 weeks after LAIV or saline spray). Selecting
for differentially expressed genes over time with abso-
lute log2 fold change greater than 0.7 and p value less
than 0.01 revealed 297 differentially expressed genes
in the control group and 58 differentially expressed
genes in the LAIV group. Hypergeometric testing for
the enrichment of gene ontology (GO) [35, 36] terms
in the up-regulated gene expression list for the LAIV
group revealed 22 meaningful biological process, all re-
lated to immune responses and most related to antigen
processing or lymphocyte activation (Fig. 5, Additional file
7: Table S3). The enriched GO terms in the control group,
however, revealed only 8 biological processes that were
non-specific, many of which involved ciliary function
(Additional file 8: Table S4). Gene set enrichment testing,
which was corrected for inter-gene correlation, showed a
statistically significant up-regulation in both type I (Fig. 6a)
and type II (Fig. 6b) interferon-stimulated genes (ISG) in
the LAIV group when compared to expression in control
group. The list of ISGs is provided in Additional file 9:
Table S5.
Effect of type I IFN on persistence of Staphylococcus aureus
in murine nasal model of colonization
Given the robust induction of IFN signature genes fol-
lowing live attenuated influenza vaccine in the host
transcriptional response, we sought to determine whether
IFNs could enhance nasal colonization of S. aureus. We
first established a mouse model of S. aureus nasal
colonization (based upon work by Kiser, et al. [37]) but
specifically used a methicillin-resistant strain of S. aur-
eus given the epidemiologic importance of secondary
MRSA infections following influenza. We found that
wildtype (WT) mice develop more persistent S. aureus
levels following intranasal instillation of MRSA com-
pared to animals deficient in the type I IFN receptor
(IFNAR KO, adjusted p = 0.008), with a trend towards
decrease persistence of MRSA in animals deficient in
type II IFN receptor (IFNGR KO, adjusted p = 0.14,
Fig. 7a). To mimic the effects of LAIV on the interferon
response, we next pretreated animals with intranasal
poly I:C, which is a synthetic compound that mimics
dsRNA present during viral infections, including influ-
enza. We have previously shown that similar to influenza,
Fig. 5 A heat map of log2 gene expression for the most differentially expressed genes in the LAIV group, selected by thresholds of p value <0.01 and
log2 fold changes greater than 0.7 between visits. The left hand column shows selected gene ontology associations from the hypergeometric GO/BP
analysis as described. Given significant overlap between gene ontology terms, representative groups were chosen to represent as many unique and
non-overlapping GO/BP terms as possible
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as downstream IFN-inducible genes such as IP-10 [38].
We examined whether MRSA persistence was dependent
upon type I IFN, type II IFN, or both by administering in-
tranasal poly I:C for 3 days to WT, IFNAR KO, and
IFNGR KO animals, followed by intranasal MRSA instilla-
tion. We found that type I IFNs appear to promote the
persistence of MRSA in the nares, as the animals deficient
in type I IFN receptor had decreased bacterial burden
(adjusted p = 0.08, Fig. 7b) at 24 hours compared to WT
counterparts, whereas the absence of type II IFN had
negligible effects on MRSA persistence. This suggests that
type I interferons may contribute to the persistence of
nasal Staphylococcus species, including MRSA.Discussion
Upper respiratory viral infections are frequently compli-
cated by secondary bacterial infection [3, 6, 7]. Accordingly,
we sought to determine whether an influenza virus infec-
tion might lead to changes in the nasal microbiota, thereby
providing insights into interactions between host response
and bacterial community structure. Previous studies include
cross-sectional surveys of various upper respiratory samples
from patients with pandemic H1N1 influenza infection
[30, 39] and oropharyngeal samples from inpatients with
acute viral infections [31]. These studies revealed no clear
“post-viral signature microbiota” given the considerable
heterogeneity in bacterial composition among individuals.
In contrast, we obtained serial samples during viral
A B

































































Fig. 6 Gene set enrichment analysis for type I (a) and type II (b) interferon-stimulated genes in our expression sets. These figures demonstrate a
probability density function for each gene, the center of which is marked by a vertical line on each x-axis. Distributions that lie predominantly to
the right of the 0 mark are more likely up-regulated, while those to the left are not. Peaked and therefore narrower functions are represented by
green colors, while broader distributions will tend towards the color blue. The sum of these functions, corrected for inter-gene correlation, is
represented by a thick black distribution for each group. The LAIV group is shown on the upright graph, and the control group is drawn in
the opposite direction for comparison. The LAIV group showed significant gene set enrichment in both types I and II interferon sets, when
compared with the control group (p < 0.05)
Tarabichi et al. Microbiome  (2015) 3:74 Page 9 of 16perturbation to detect within subject changes in order to
provide greater statistical power for our analyses. Add-
itionally, our study is the first to compare dynamic
changes of the nasal microbiota and host gene expression
from baseline after an acute influenza challenge when
compared to saline receiving controls. This design permit-


























Fig. 7 MRSA colonization is type I interferon-dependent. a Wild type (WT)
receptor knockout mice (IFNGR KO) underwent intranasal instillation of MR
using 200 μl of sterile saline for enumeration of CFU. b wild type, IFNAR, and
for 3 days, followed by i.n. MRSA (6.7 × 107 CFU). Twenty-four hours later, nasa
Kruskal-Wallis ANOVA with Dunn correction for multiple comparisons)viral stimulus against stochastic time-dependent differ-
ences. Despite our limited sample sizes, our approach
allowed us to demonstrate small but significant differences
in bacterial community structure and host immune
response after viral perturbation. As anticipated, we ob-
served great inter-subject heterogeneity of the nasal























MRSA after Poly I:C
C57Bl/6 mice, type I IFN receptor knockout (IFNAR KO), and type II IFN
SA (6.7 × 107 CFU). Twenty-four hours later, nasal lavage was performed
IFNGR knockout mice were administered intranasal poly I:C (50 mcg) daily
l lavage was performed for enumeration of CFU. (**adjusted p < 0.01 by
Tarabichi et al. Microbiome  (2015) 3:74 Page 10 of 16heterogeneity were we able to demonstrate significant, al-
beit small, changes in community structure with viral per-
turbation, based on Bray-Curtis similarities.
Similar to earlier studies, we observed a general pre-
ponderance of three dominant phyla—Actinobacteria,
Firmicutes, and Proteobacteria—in all nasal samples
[31, 39–45]. Core membership in the control group
over time and the LAIV group prior to perturbation
consisted of only three core genera—Staphylococcus,
Corynebacterium, and Propionibacterium. The core
membership expanded after LAIV administration to
include Streptococcus and Bacillales, among others.
Notably, the number of subjects and our sequencing
depth were greater than an earlier study examining the
nasal microbiota pre- and post-rhinovirus experimental
challenge [40], which enhanced our ability to detect sig-
nificant differences in individual bacterial taxa. We were
able to detect a significant increase in Staphylococcus
relative abundance after LAIV administration. The dif-
ference in Staphylococcus abundance between the groups
receiving saline or LAIV was particularly striking among
subjects with low baseline levels of Staphylococcus.
Although we were unable to confidently assign species
of Staphylococcus, our animal data demonstrated that
induction of an antiviral immune response promotes
persistence of S. aureus. This supports a recent study
where LAIV administration enhanced nasal colonization
by MRSA and S. pneumoniae in a murine model [46].
Future studies will delve into the mechanisms by which
Staphylococcus species may be permitted to outgrow
other commensal bacteria in the upper respiratory tract.
Interestingly, we also observed the emergence of Bac-
teroides, an obligate anaerobe, after intervention in the
LAIV group. While the absolute change was statistically
significant in that group, the relative abundances were
low, and the clinical relevance of this finding in the re-
spiratory tract is not clear. However, these gram-negative
microorganisms are typically noted to be anaerobic and
associated with the gut microbiota where they can influ-
ence the host immune system and play both commensal
and pathologenic ecological roles in part due to their di-
verse metabolic capabilities, including complex carbohy-
drate metabolism and biofilm formation [47]. It is possible
that they may take on similar roles in the upper respira-
tory tract; thus, further study may be warranted.
Intertaxonomic bacterial interactions are of interest in
determining how the microbiota is shaped within indi-
viduals. Of mounting interest in the study of the nasal
microbiota is the determination of factors associated
with the carriage of potentially pathogenic bacteria, includ-
ing S. pneumoniae and S. aureus. Either of these organisms,
when implicated in co-infection, leads to poorer clinical
outcomes during influenza infection [2, 6, 19, 48, 49]. This
link has prompted numerous investigators to seekassociations or interactions between these pathogenic or-
ganisms and what may be considered “normal” commen-
sals. Prior studies have reported an observation similar to
ours, where the relative abundance of Staphylococcus is
inversely proportional to the relative abundance of Cor-
ynebacteria [43, 50–52]. In support of this finding, Yan
et al. demonstrated the inhibition of S. aureus by C.
pseudodiptheriticum in vitro [52]. In parallel, Frank
et al. [50] found that hospitalized patients had Firmi-
cutes dominant profiles (relative abundance of 71 %)
while the relative abundance of Actinobacteria proved
smaller (20 %), supporting a pre-pathogenic potential
in compromised hosts. This seemingly exclusive com-
petition was also shown in a study by Uehara et al. [51]
where a previously harvested strain of Corynebacterium
was implanted in the nares of S. aureus carriers, leading
to an eradication rate of 71 %, a result not replicated by
saline or S. epidermidis implantation. However, given
that microbiota data is compositional in nature, taxo-
nomic correlations need to be estimated based on the
(ALR) transformed abundances in order to avoid spurious
correlations caused by scaling. Hence, our conclusions dif-
fer in that the three most abundant taxa (Staphylococcus,
Corynebacterium, and Propionibacterium) appear to be
positively correlated, which we believe reflects an overall
stability in the bacterial community. These findings
suggest that the factors that govern overall microbiota
composition are in fact remarkably complex. Rather
than focusing on individual bacterial proportions per
se, perhaps a better grasp of the ecological characteris-
tics of the nasal niche obtained via host and microbial
metagenomic analysis might provide mechanistic in-
sights into why certain bacteria persist in different
individuals.
Since host immune response is one potential factor
governing the changes in the bacterial composition, we ob-
tained concurrent host response gene expression data pre-
and post-LAIV administration. Despite their essential role
in antiviral immunity, studies from our group and others
have shown that the type I and II interferon responses are
associated with suppression of the antibacterial component
of the innate immune system in animal models of influenza
and bacterial co-infections [21, 22, 25]. Moreover, type I
IFNs are associated with enhanced colonization by S. pneu-
moniae in a murine model of nasal bacterial colonization
[20]. Hence, we designed our study to determine whether
experimental intranasal administration of LAIV would in-
duce an IFN-mediated immune signature [53–55]. Hyper-
geometric gene set enrichment by conservative measures
showed a statistically significant up-regulation in interferon
types I and II stimulated genes in the LAIV group. Our
results support a prominent local immune reaction in the
nares after LAIV administration, as well as highlight a sub-
stantial role for ISG after the first week. Hence, we were
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to induction of an interferon immune signature at the time
we saw the most significant changes in the nasal microbiota
following LAIV. Furthermore, nasal administration of a
viral ligand in a murine model led to increased persistence
of MRSA in a type I interferon-dependent fashion. As
LAIV has not been reported to predispose to secondary
bacterial infection, it is likely that additional immune de-
fects or perhaps structural changes in the respiratory epi-
thelium induced by viral infection are necessary for the
development of invasive disease. Nonetheless, increased
colonization by potentially pathogenic bacteria may repre-
sent a critical first step.
Our study is not without limitations. The number of
volunteers in each group was small; however, there were
three samples obtained from each volunteer at different
time points, allowing greater power with the benefit of
paired statistical methods. Another limitation to our ap-
proach was an inability to make confident assignments
of species to Staphylococcus operational taxonomic unit
(OTUs) due to the less than 3 % difference in the V1–V3
regions between S. aureus and S. epidermidis. Finally, an-
other limitation pertains to culture-independent 16S rRNA
gene sequencing and that is the inability to distinguish live
organisms from transient microorganism colonization, par-
ticularly with the potentially significant quantity of inhaled
bacterial burden [56]. Additional repeated measures, i.e.,
increasing sample periodicity, from the same donor across
all treatment cohorts, would improve our understanding of
the rate of microbiota change and its potential variability
and limits. This would provide a clearer relationship be-
tween donor treatment and cessation of symptoms versus
the microbiota’s recovery towards “normality.” Identifying
such lags might provide an avenue for better understanding
cause and effect, instead of correlation alone.Conclusions
In summary, LAIV administration was associated with
clinically meaningful changes in nasal epithelial gene
expression that mirrored those expected of natural
influenza infection, including activation of interferon-
stimulated pathways, which have recently been implicated
in diminished antibacterial activity and enhanced bacterial
colonization in murine models. Along with these host
gene expression changes, LAIV led to significant changes
in bacterial community structure with increases in the
relative abundance of Staphylococcus and Bacteroides gen-
era. These changes support murine models and clinical
findings, suggesting that they represent the first steps to-
wards the emergence of potentially pathogenic bacteria
during natural upper respiratory tract infection. Further
investigation is needed to better appreciate these com-
plex host-microbiota interactions in true disease states.Methods
Enrollment
This study alternately assigned non-blinded cohorts of
paid healthy adult volunteers to either LAIV: (FluMist,
influenza vaccine, live; MedImmune) or saline nasal
spray (Additional file 10: Figure S5). Volunteers were be-
tween the ages of 18 and 65 years and were without known
medical problems. Any subjects with nasal ailments, on im-
munosuppressive medication (including nasal steroid spray
or prednisone dose ≥20 mg or equivalent), exhibiting re-
spiratory infection or antibiotic use within the last 90 days
or with known chronic conditions were excluded. Upon
volunteering, subjects were screened with a questionnaire
that obtained general identifiers, contact information, and
demographics such as age, sex, and ethnicity. Relevant data
to the study included prior medical history, medication, or
probiotic usage. Also addressed were the presence of habit-
ual nose-picking and personal hygiene measures including
frequency of bathing or showering, as well as swimming.
We also recruited adults who presented as outpatients
to our emergency department or general internal medi-
cine clinics with flu-like illness (FL), which we defined as
having fever and symptoms of upper respiratory illness.
The study was reviewed and approved beforehand by
our human subjects institutional review board (UCLA
IRB IRB#11-000326). The investigators received in-
formed consent from all study participants.
Sampling
Specimens were collected using sterile, dry swabs (Epi-
Centre). A total of four swabs (two from left nares, two
from right) were obtained from each subject at enrollment
and repeated at 1–2 weeks and then 4–6 weeks after initial
presentation. In addition, subjects underwent nasal lavage
with 10 ml of sterile non-microbiostatic saline at each time
point. Following lavage, nasal brushings were obtained for
extraction of host RNA for microarray analysis. For the FL
group, we obtained serial samples during acute viral illness, 1–
2 weeks later, and at 6–8 weeks after the initial presentation.
Nucleotide extraction and pyrosequencing
The nasal swabs and lavage from each individual were
pooled for isolation of bacterial genomic DNA (gDNA)
using the PowerSoil DNA Isolation Kit (Mo-Bio laborator-
ies). At the time of sample extraction, a negative control
consisting of extraction reagents was included. V1–V3
and V3–V5 hypervariable regions of the 16S ribosomal
RNA gene were amplified by PCR with barcoded primers
designed using a set of algorithms developed at the J.
Craig Venter Institute (JCVI) [57]. Prior to amplification,
the PCRs were set up using precautions to reduce exogen-
ous DNA contamination including use of a laminar flow
hood and dispensing of reagents with pipettors restricted
to PCR reagent use only (no gDNA).
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reaction): 2 μL of gDNA (~2–5 ng total), 0.75 units of Q5®
High-Fidelity DNA Polymerase (New England Biolabs,
MA) and 1× final concentration of Q5® High-Fidelity
Master Mix. Primers were added to a final concentration
of 200 nM, with dNTPs at a final concentration of
200 μM, along with the Q5 High GC Enhancer for ampli-
fication to a 1× final concentration and nuclease-free
water to bring the final volume to 20 μL. PCR cycling con-
ditions were as follows: initial denaturation of 30 s at 98 °
C followed by 30 cycles of 98 °C for 10 s, 30 s at 56 °C,
and 72 °C for 60 s, followed by a final incubation at 72 °C
for 5 min before cooling to 4 °C. Negative controls (water
blank) for PCR were also included. Negative controls
(PCR and gDNA extraction controls) were subjected to an
additional five cycles of PCR beyond the 30 cycles used for
the experimental samples (35 cycles total). All PCR (2.5 μl
from experimental samples, 10 μl from controls) were
visualized on 1 % agarose gels. No visible bands of the
expected amplicon size were detected from any of the
negative controls.
Each reaction was cleaned individually using the Agen-
court XP beads (Beckman Coulter, Inc., Indianapolis, IN)
and resuspended in 30 μL of water prior to normalization
and pooling of samples for sequencing. Amplicons were
quantitated using the Quant-iT PicoGreen dsDNA Assay
Kit (Life Technologies, Grand Island, NY) and then nor-
malized amounts of each sample were combined into one
pool prior to purification using a QIAQuick PCR Purifica-
tion column (Qiagen, Valencia, CA) and submitted for
sequencing with the Roche-454 FLX Titanium platform.
The pooled samples were further cleaned using the
Agencourt AMPure system (Beckman Coulter Genomics,
Danvers, MA) prior to emulsification PCR (emPCR). Steps
for emPCR, enrichment, and 454 sequencing were per-
formed by following the vendor’s standard operating pro-
cedures. Real-time PCR was used to accurately estimate
the number of molecules needed for emPCR. Total RNA
was extracted from a subset of the specimens, and 18
samples were submitted for expression profile analysis
by Affymetrix chip hybridization, following manufacturer
recommendations [57].
Microbiota analysis
After sequencing, a read processing pipeline consisting
of a set of custom perl scripts designed to efficiently for-
mat large datasets designed at the JCVI [32, 58] along
with the mothur pipeline [59] were employed for decon-
volution, trimming, and quality-filtering. Reads were first
deconvoluted, i.e., assigned to samples based on their
unique 10-nt barcode allowing no more than a one
nucleotide mismatch to the barcode. After deconvolu-
tion, barcode and 16S primer sequences were removed
allowing a maximum of six mismatches to the 16S primerand a maximum primer to barcode distance of 3 nt. The
majority of primer matches (74.27 % perfect match +
22.23 % one mismatch = 96.5 %) of reads had one or fewer
mismatches. Quality trimming of reads was performed
using mothur. Reads with an average length of <100 nt
and reads with “Ns” or with ambiguous base calls or a
homopolymer longer than 8 nt were removed from subse-
quent analyses. A Blastn quality check was performed
against an internal data set of 16S rRNA gene sequence
reads to remove any sample reads not consistent with 16S
rRNA gene sequences, in which at least 30 % of the query
must be covered by the alignment (60 nt minimum).
Passing reads were subsequently further processed in-
cluding chimera checking through the mothur pipeline.
After quality control processing, the high quality reads
remaining were further examined using both taxonomy
dependent (classification) and taxonomy independent
(OTU formation) approaches. All steps through the gener-
ation of data matrices of taxonomic profiles were per-
formed using the mothur pipeline. This includes generation
of taxonomic classifications using the naïve Bayesian classi-
fication algorithm as implemented in mothur in conjunc-
tion with the SILVA database and formation of OTUs at
97 % sequence identity as well as subsequent taxonomic
classification of the OTUs. Sequences for the project are
publicly available at GenBank: PRJNA222379 [59].
Distance-based analyses
Metric multidimensional scaling plots were generated
with the help of the Vegan package in R (https://www.r-
project.org/), with distances based on Bray-Curtis dis-
similarities [60]. Inter-sample comparison with permuta-
tional multivariate analysis of variance (PERMANOVA)
based on Bray-Curtis dissimilarities were performed using
the Adonis function within the Vegan package. To control
for inter-subject variability, the linear model utilized was
distance = visit + treatment + visit × treatment + error, with
stratification by subject. The factors under consideration
were based on the treatment by visit interaction when
more than two groups were analyzed, versus visit alone
when a single group was analyzed. Results were reported
based on bootstrapped p value and associated unadjusted
R2. The dispersion analysis was performed by estimating
the residuals for each sample by element-wise multiplying
the estimated coefficients matrix (B(p × n)) by the trans-
posed model matrix (X(n × p))', where p is the number of
regression coefficients estimated and n is the number of
samples. With the resultant matrix, the absolute value of
each column was summed, thus representing the total re-
siduals associated with each sample. For each possible pair
of groups, the median residual values underlying each
group were compared for equality using the non-
parametric Wilcoxon rank sum testing. p values were not
corrected for multiple testing.
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Normalized taxonomic abundance profiles were computed
for each taxonomic category by dividing the number of
reads assigned to a taxon by the total read count in each
sample. The Shannon diversity index was calculated using
Vegan, and the tail statistic, which is a rank-based diversity
metric for analyzing low abundance taxa, was calculated
as described by Li et al. [61]. Two-way, repeated measures
ANOVA for the tail statistic and Shannon index were indi-
vidually achieved in JMP version 11. The factors analyzed
were visit (as a repeated measure) and study intervention.
For the correlation analysis between taxa, the (ALR)
transform was performed by dividing each of the 15
most abundant genera by the sum of the relative abun-
dances of the remaining non-top 15 genera. These ratios
were then natural log transformed. To prevent perform-
ing the natural logarithm transformation on an abun-
dance of 0, taxa with zero abundance were replaced with
1/10th of the lowest non-zero abundance across all sam-
ples and taxa. ALR transformed abundances are less
prone to spurious correlation due to normalization since
each transformed value is a ratio between its abun-
dance and the reference “remaining” abundance. The
top 15 taxa represented close to 92 % of the taxa by
abundance.
Corbata plots
Core microbiota analysis U-U plots were generated using
Corbata [62]. Briefly, for each taxon in a group of samples,
the relationship between abundance and ubiquity is calcu-
lated. Then, for each pair of groups, at matching abun-
dances, a curve is generated to indicate the relative
ubiquity of each taxon in each group. See the Material and
Methods in Li 2013 [33] for a mathematically rigorous de-
scription of the algorithm. For interpretation, if groups A
and B are represented on the x- and y-axis, respectively, if
a taxon tends to be in greater ubiquity in group A then its
curve will meander towards the bottom right of the plot
(i.e., deviate from the diagonal line towards the x-axis). If
the taxon tends to be in greater ubiquity in group B, then
it will meander towards the top left of the plot or y-axis.
When there is no difference between the ubiquity of a
taxon between two groups, the curve will plot on the diag-
onal reference line. The Ub-Ab plot, also found in the
Corbata suite of tools, represents the ubiquity of a taxon
across all members of a cohort, as a function of abun-
dance. Core taxa are defined as those taxa that are found
in a majority of samples, at a significant abundance. Core
taxa, which tend to be high in abundance and ubiquity
can be identified by curves seeking the top right of the
plot. While there are no standard ubiquity and abundance
cutoffs, the 80 % ubiquity and 0.5 % abundance thresholds
were chosen based upon their frequent ability to distin-
guish between the relatively few characteristic taxa fora body habitat and the remaining “background” taxa
[33].
When the sample sizes are relatively small, U-U and
Ub-Ab plot curves will be more jagged and step-shaped.
Thus, smoothing was performed with bootstrapping by
sampling with replacement of both the samples and
reads during each bootstrap iteration. Also, frequently
the U-U curve between two groups will fall along the
diagonal, signifying that there is not a significant differ-
ence between the ubiquity of a taxon at all abundances
between two cohorts. To improve the visualization, only
taxa that were statistically significantly different using
the Kolmogrov-Sminorv test were plotted.Microarray analysis
Extraction of RNA from nasal epithelial brushes was per-
formed in the UCLA Clinical Microarray Core using the
MagnaPure Compact automated system (Roche), which
minimizes DNA contamination. RNA integrity was per-
formed using the Eukaryote Total RNA Pico assay on the
Agilent 2100 Bioanalyzer system. RNA quantification was
determined by the NanoDrop 8000. For quality control as-
sessment, the Affymetrix chips were inspected visually and
felt to be free of gross spatial defects. More detailed ana-
lyses of the scanned data were obtained through the affyQ-
Creport package of the Bioconductor project in R [63].
Intensity plots of individual chips were comparable, over-
lapping without outliers. Normalized unscaled standard
error (NUSE) plots aligned across all chips. There was also
the notable absence of significant variability between the
percentage present and average background values in each
chip. RNA degradation plots of each chip converged with
similar slopes, suggesting agreement in the degrees of RNA
digestion. As recommended by the manufacturer, all chips
showed appropriate levels of expression for β-actin, though
GADPH expression was just above the recommended level
on three chips (two in the control group and one from
the experimental group). Finally, inspection of the posi-
tive and negative border elements revealed positive and
negative controls grouping in distinct intensity ranges,
as expected.
Expression data was extracted using the affybatch pack-
age of the Bioconductor project in R. Background adjust-
ment, normalization, and summarization were achieved
across both sets independently (LAIV and control) using
the well-established RMA or “robust multichip average”
method [64–66]. Non-specific filtering was achieved with
the nsFilter function, removing 50 % of genes with the
lowest variance across all the chips, as well as gene IDs
that did not match to an Entrez ID or matched to more
than one Entrez ID. After filtering, the lmFit and
eBayes functions were used to perform moderated
paired t testing for each gene across visits 1 and 2.
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formed with the QuSAGE package in R [67], comparing
our processed gene lists against those from a prior study
of A549 cell lines subjected to α or γ interferon [68].
Genes of interest from either group were then selected
based on those with absolute log2 fold changes greater
than 0.7 and individual p values less than 0.01. Both
sets of up-regulated genes were subjected to conditional
hypergeometric testing via the GOstats package to shed
light on any potentially grouped biological processes [69].
Only the resultant processes with reported individual p
values of less than 0.001 were reported. A heat map was
generated from the gene list obtained from the LAIV arm
using the heatmap.2 function in the gplots package, clus-
tered by gene expression and with supervised labeling of
up-regulated GO/BP functions based on prior hypergeo-
metric testing.Animal model of nasal colonization
Age- and sex-matched mice with a C57BL/6 genetic
background were used in all experiments. Wildtype (WT)
C57BL/6, type I IFN receptor knockout (IFNAR KO) and
type II IFN receptor knockout (IFNGR KO) animals
were bred and housed in in-house colonies. For nasal
colonization experiments, Los Angeles County (LAC)
strain of methicillin-resistant S. aureus (MRSA) was used.
Bacteria were grown overnight in tryptic soy broth in a
shaking incubator at 37 °C, followed by 4-h subculture the
following morning. An innoculum of 6 × 107 colony-
forming units (CFU) total was placed in the nares of each
animal under anesthesia (intraperitoneal ketamine and
xylazine (n = 5 animals/group). Poly I:C (50 μg in 50 μl) or
sterile saline control was nasally instilled daily for 3 days
prior to MRSA innoculation, where applicable (n = 6 ani-
mals/group). At 24 h after MRSA nasal instillation, ani-
mals were sacrificed for performance of nasal lavage with
200 μl of sterile saline to determine degree of persistence
[70]. Bacterial CFU were enumerated by plating 10 μl of
nasal lavage samples on TSA agar using 1:5 serial dilutions
and back-calculated to determine the total number of
CFU in nasal lavage fluid. All animal experiments were
performed in accordance with NIH policies regarding the
humane care and use of laboratory animals and were
approved by the UCLA Office of Animal Research Over-
sight (OARO protocol 2005-143).Additional files
Additional file 1: Figure S1. Panel A demonstrates dispersion from the
individual centroids for all groups across three visits based on Bray-Curtis
dissimilarities in the aforementioned all-inclusive PERMANOVA model. Panel
B shows resultant p values for each comparison between these groups
using the Wilcoxon rank sum test. Red squares depict comparisons that are
significant. V1 = visit 1, V2 = visit 2 and V3 = visit 3.Additional file 2: Figure S2. Ubiquity-ubiquity plot contrasting the
ubiquities of a number of selected taxa, across a range of relative
abundances between visits 1 and 2 in the control group as ascertained
by hypervariable region V3–V5 sequencing. Only OTUs with a relative
abundance greater than 0.5 % and change in ubiquity greater than 20 %
were included in this plot. OTUs that aligned to the right of the diagonal
were more ubiquitous during visit 1, while those to the left were more
ubiquitous at visit 2.
Additional file 3: Figure S3. Ubiquity-abundance plots for each group,
by visit. These figures plot OTU ubiquities across a range of relative
abundances, highlighting (with coloring and labels) OTUs at a threshold
of at 80 % ubiquity and greater than 1 % relative abundance
(represented by the red target) as ascertained by hypervariable region
V3–V5 sequencing. This threshold reveals the “core” taxa.
Corynebacterium, Staphylococcus, and Propionibacterium emerge as the
core taxa at both time points in the control group and at the first visit in
the LAIV group. The core taxa expanded by the second visit in the LAIV
group to include, Streptococcus and Bacillales, among others.
Additional file 4: Figure S4. Graphic representation of the relative
abundance of Staphylococcus over time in subjects classified as having a
low baseline level of Staphylococcus (i.e., below 10 %) at their first visit.
The blue points represent the control group while the red points
represent members of the LAIV group.
Additional file 5: Table S1. Significant correlations among the most
abundant genera for samples in the control and LAIV cohort. Pearson
correlation coefficients (ρ) were calculated between the ALR transformed
abundances for genera identified with the V1–V3 hypervariable regions
of the 16S rDNA genes. Only genera with p values <0.05 (uncorrected for
multiple testing) are provided below. The control and LAIV cohort used
in this analysis consisted in total of 50 samples.
Additional file 6: Table S2. Significant correlations among the most
abundant genera with control, LAIV, and FL samples. Similarly to Table
S1, Pearson correlation coefficients (ρ) were calculated between the ALR
transformed abundances for genera identified with the V1–V3 regions.
Only genera with p values <0.05 (uncorrected for multiple testing) were
provided below. The control, LAIV, and flu-like cohort consisted in total of
107 samples. In support to the results shown in Table S1, the positive
correlation between Propionibacterium and Staphylococcus and between
Dolosigranulum and Corynebacterium seem to be reinforced with the
addition of the FL cohort.
Additional file 7: Table S3. Hypergeometric testing for the enrichment
of GO/BP terms in the LAIV group.
Additional file 8: Table S4. Hypergeometric testing for the enrichment
of GO/BP terms in the control group.
Additional file 9: Table S5. Type I and type II Interferon-stimulated
gene list.
Additional file 10: Figure S5. Flowchart of sampling procedures for
subjects administered LAIV versus saline.Abbreviations
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